TrialResults - center   -  Clinical trials results database in cardiology

GAMMA

You are here:  Home > Search and browse > Browse treatment 3

Overview of clinical data for dabigatran

Clinical trials of dabigatran (Pradaxa, Pradax) and meta-analysis are available for the following clinical conditions:

atrial fibrillation

atrial fibrillation, antithrombotics, primary prevention of thromboembolic events

dabigatran vs warfarin standard dose :  phase 2 dabigatran (unpublished)  -  RE-LY (110mg) ,2009  -  PETRO (150mg) ,2007  -  RE-LY (150mg) ,2009  - 

atrial fibrillation, direct antithrombins, all type of patients

dabigatran 110mg vs warfarin standard dose :  RE-LY (110mg) ,2009  -  PETRO (150mg) ,2007  -  RE-LY (150mg) ,2009  - 

atrial fibrillation, new anticoagulants, all type of patients

dabigatran vs warfarin standard dose :  phase 2 dabigatran (unpublished)  -  RE-LY (110mg) ,2009  -  PETRO (150mg) ,2007  -  RE-LY (150mg) ,2009  - 

atrial fibrillation, antithrombotics, secondary prevention of thromboembolic events

dabigatran 100mg vs warfarin :  RE-LY 110mg subgroup ,2010  -  RE-LY 150mg subgroup  - 

DVT prophylaxis

DVT prophylaxis, antithrombotics, orthopedic surgery

dabigatran 150mg vs enoxaparin :  RE-MODEL (150mg) ,2007  -  RE-NOVATE (150mg) ,2007  -  RE-MOBILIZE (150mg) ,2008  -  RE-MOBILIZE (220mg) ,2008  -  RE-MODEL (220mg) ,2007  -  RE-NOVATE (220mg) ,2007  -  RE-NOVATE 2 ,2010  -  BISTRO II (225mg bid) ,2005  - 

DVT prophylaxis, antithrombotics, elective major knee surgery

dabigatran 150mg vs enoxaparin :  RE-MODEL (150mg) ,2007  -  RE-MOBILIZE (150mg) ,2008  -  RE-MOBILIZE (220mg) ,2008  -  RE-MODEL (220mg) ,2007  - 

DVT prophylaxis, antithrombotics, elective hip replacement

dabigatran 150mg vs enoxaparin :  RE-NOVATE (150mg) ,2007  -  RE-NOVATE (220mg) ,2007  -  RE-NOVATE 2 ,2010  - 

DVT prophylaxis, anticoagulant, orthopedic surgery

dabigatran 150mg vs enoxaparin :  RE-MODEL (150mg) ,2007  -  RE-NOVATE (150mg) ,2007  -  RE-MOBILIZE (150mg) ,2008  -  RE-MOBILIZE (220mg) ,2008  -  RE-MODEL (220mg) ,2007  -  RE-NOVATE (220mg) ,2007  -  RE-NOVATE 2 ,2010  -  BISTRO II (225mg bid) ,2005  - 

DVT prophylaxis, direct antithrombins, all type of patients

dabigatran 150mg vs enoxaparin :  RE-MODEL (150mg) ,2007  -  RE-NOVATE (150mg) ,2007  -  RE-MOBILIZE (150mg) ,2008  -  RE-MOBILIZE (220mg) ,2008  -  RE-MODEL (220mg) ,2007  -  RE-NOVATE (220mg) ,2007  -  RE-NOVATE 2 ,2010  -  BISTRO II (225mg bid) ,2005  - 

DVT prophylaxis, new anticoagulants, all type of patients

dabigatran 150mg vs enoxaparin :  RE-MODEL (150mg) ,2007  -  RE-NOVATE (150mg) ,2007  -  RE-MOBILIZE (150mg) ,2008  -  RE-MOBILIZE (220mg) ,2008  -  RE-MODEL (220mg) ,2007  -  RE-NOVATE (220mg) ,2007  -  RE-NOVATE 2 ,2010  -  BISTRO II (225mg bid) ,2005  - 

DVT prophylaxis, new anticoagulants, elective major knee surgery

dabigatran 150mg vs enoxaparin :  RE-MODEL (150mg) ,2007  -  RE-MOBILIZE (150mg) ,2008  -  RE-MOBILIZE (220mg) ,2008  -  RE-MODEL (220mg) ,2007  -  BISTRO II (225mg bid) ,2005  - 

DVT prophylaxis, new anticoagulants, elective hip replacement

dabigatran 150mg vs enoxaparin :  RE-NOVATE (150mg) ,2007  -  RE-NOVATE (220mg) ,2007  -  RE-NOVATE 2 ,2010  -  BISTRO II (225mg bid) ,2005  - 

post acute coronary syndromes

post acute coronary syndromes , antithrombotics, all type of patients

dabigatran vs placebo :  REDEEM ,2009  - 

post myocardial infarction

post myocardial infarction, antithrombotics, all type of patients

dabigatran vs placebo :  REDEEM ,2009  - 

venous thrombosis

venous thrombosis, antithrombotics, all type of patients

dabigatran vs vitamin K antagonists :  RE-COVER ,2009  - 

venous thrombosis, direct antithrombins, all type of patients

dabigatran vs vitamin K antagonists :  RE-COVER ,2009  - 

pdf version

Entry terms: BIBR 1048, dabigatran etexilate, BIBR 1048, 3-((2-((4-amino((E)-hexyloxycarbonylimino)methyl)-phenylamino)methyl-1-1H-benzoimidazole-5-carbonyl)pyridin-2-yl-amino)propionic acid ethyl ester

See also relatic topics:

• direct antithrombins
• direct antithrombins in DVT prophylaxis
• direct antithrombins in atrial fibrillation
• direct antithrombins in venous thrombosis
• clinical trials of Pradaxa
• clinical trials of Pradax

Search dabigatran clinical trials in Pubmed

Search dabigatran clinical trials in ClinicalTrials.gov

Search dabigatran clinical trials in Wikipedia

Search dabigatran in drugs.com

browse_trt3

This site complies to the HONcode standard for trustworthy health information: verify here.

Last uptaded on 2010/11 22 user(s) connected

TrialResults-center database by TrialResults-center is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License .

OpenSearch feed - Add TrialResults-center.org to your browser's search bar